Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -15.04% is 21% above its 5-year average of -18.92%, around the middle of its 5-year range (-30.81%–-6.62%).
24.55% above its 12-month average of -19.94%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 1.14%.
RETURN ON ASSETS (ROA)
-15.04%
RETURN ON ASSETS (ROA) AVG TTM
-19.94%
RETURN ON ASSETS (ROA) AVG 3Y
-19.35%
RETURN ON ASSETS (ROA) AVG 5Y
-18.92%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+24.55%
CURRENT VS 3Y AVG
+22.26%
CURRENT VS 5Y AVG
+20.51%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+53.35%
vs the sector median at left
P3 Health Partners Inc.
Market Cap
$19.43M
Return on Assets (ROA)
-15.04%
TTM Avg
-19.94%
3Y Avg
-19.35%
5Y Avg
-18.92%
Market Cap
$18.67M
Return on Assets (ROA)
-64.55%
TTM Avg
-0.45%
3Y Avg
-55.72%
5Y Avg
-45.67%
Market Cap
$18.76M
Return on Assets (ROA)
-393.39%
TTM Avg
-225.59%
3Y Avg
-343.91%
5Y Avg
-343.91%
Market Cap
$20.47M
Return on Assets (ROA)
-188.98%
TTM Avg
-90.06%
3Y Avg
-67.42%
5Y Avg
-51.71%
Market Cap
$18.03M
Return on Assets (ROA)
-39.68%
TTM Avg
-29.52%
3Y Avg
-26.86%
5Y Avg
-20.28%
Market Cap
$17.99M
Return on Assets (ROA)
-548.74%
TTM Avg
-346.44%
3Y Avg
-242.08%
5Y Avg
-167.09%
Market Cap
$20.99M
Return on Assets (ROA)
-173.14%
TTM Avg
-158.95%
3Y Avg
-120.45%
5Y Avg
-102.27%
Market Cap
$17.17M
Return on Assets (ROA)
-59.70%
TTM Avg
-56.25%
3Y Avg
-61.89%
5Y Avg
-61.99%
Market Cap
$17.11M
Return on Assets (ROA)
-49.72%
TTM Avg
-28.29%
3Y Avg
-39.08%
5Y Avg
-40.04%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| P3 Health Partners Inc. (PIII) | $19.43M | -15.04% | -19.94% | -19.35% | -18.92% |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.67M | -64.55% | -0.45% | -55.72% | -45.67% |
| Actuate Therapeutics Inc (ACTU)vs › | $18.76M | -393.39% | -225.59% | -343.91% | -343.91% |
| NextCure, Inc. (NXTC)vs › | $20.47M | -188.98% | -90.06% | -67.42% | -51.71% |
| Cosmos Health Inc. (COSM)vs › | $18.03M | -39.68% | -29.52% | -26.86% | -20.28% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.99M | -548.74% | -346.44% | -242.08% | -167.09% |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.99M | -173.14% | -158.95% | -120.45% | -102.27% |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.17M | -59.70% | -56.25% | -61.89% | -61.99% |
| Lipocine Inc. (LPCN)vs › | $17.11M | -49.72% | -28.29% | -39.08% | -40.04% |
| PAVmed Inc. (PAVM)vs › | $17.04M | -30.06% | 65.41% | -56.95% | -76.50% |
ROA
-15.0%
ROE
-136.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -22.53% |
| 2024-12-31 | -17.34% |
| 2023-12-31 | -6.71% |
| 2022-12-31 | -30.81% |
| 2021-12-31 | -6.62% |
| 2020-12-31 | -29.51% |
| 2019-12-31 | -63.98% |
| 2018-12-31 | 0.00% |
